Sarah Ford | February 9, 2015
Research progress report: Frizzled 9 and lung cancer chemoprevention
Every year, lung cancer leads to more deaths than any other cancer. An estimated 159,2601Ìý¾«¶«Ó°Òµns were expected to die from lung cancer in 2014, accounting for about 27% of all cancer deaths.
The Foundation is committed to lung cancer prevention research and currently supports five researchers studying different aspects of preventing this deadly disease. One of these researchers is Meredith Tennis, Ph.D., of the University of Colorado Denver. Her project focuses on Frizzled 9, a protein that helps to maintain normal lung tissue, as a potential biomarker2Ìýto predict how patients may respond to the drug iloprost, a drug being used for chemoprevention.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
World Alzheimer’s Day
Alzheimer’s disease is the most common form of dementia, a group of disorders that impairs mental functioning. According toÌýBrightFocus, more than 6 million ¾«¶«Ó°Òµns are…
Read Article
Join Feeding ¾«¶«Ó°Òµ and Take Action During Hunger Action Month
No one should have to go hungry in the richest country in the world — yet millions of ¾«¶«Ó°Òµns don’t have enough to eat. Our…
Read Article
Childhood Cancer Awareness Month
Every September, childhood cancer organizations around the world come together in recognition ofÌýChildhood Cancer Awareness Month, withÌýa goal to increase awareness and raise funds for…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
